• SENSEX 74,529.08
    -329.91 (--0.44%)
  • BANKNIFTY 56,215.55
    -255.10 (--0.45%)
  • Pine Labs
    205.00 283.70(%)
  • HDFC Bank
    738.70 682.00(%)
  • Meesho
    244.80 254.65(%)
  • Glass Wall Syst.
    318.00 318.00(%)
  • Cholaman.Inv.&Fn
    1,756.50 1,299.80(%)
  • Solar Industries
    20,243.65 22,630.05(%)
  • Cupid
    265.35 298.95(%)
  • Aster DM Quality
    746.55 519.80(%)
  • Protean eGov
    656.45 940.00(%)
  • Gabriel India
    1,495.35 1,600.00(%)
  • Nippon ETF Liq.
    999.99 978.01(%)
  • Transrail Light
    487.90 800.35(%)
  • Reliance Industries
    1,237.80 1,232.35(%)
  • JSW Dulux
    3,131.20 2,649.05(%)
  • Kaynes Tech
    3,427.35 2,995.85(%)
  • Apar Inds.
    17,916.55 6,800.00(%)
  • Titan Company
    4,983.70 5,187.45(%)
  • Dixon Technolog.
    12,997.00 9,605.05(%)
  • Eternal
    341.80 368.40(%)
  • Larsen & Toubro
    3,867.50 3,288.65(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Kobo Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 6012.0
  • ISIN : INE881A01015
4.13 0 (-1.90%)
  • As on 23 Sep 2026 (EOD)

  • Today’s Low

    4.13

  • Today’s High

    4.13

  • Open

    4.13

  • Perv Close

    4.21

  • 52W Low

    1.99

  • 52W High

    9.99

Key Indicators

  • P/E(TTM)

    0.00

  • Mar.Cap (₹Cr.)

    9.84

  • Div & Yield %

    0.00

  • Book Value(₹)

    -57.98

  • Debt-Equity Ratio

    -1.90

  • AGM Date

    22-Sep-2026

  • EPS

    0.00

  • P/E Ratio

    0.00

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    9.84

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    23.83

  • BV (₹)

    -58.00

  • Sales( ₹ in Cr.)

    0.00

  • NP (in Cr.)

    -5.23

  • NP Var(%)

    -6.0

  • Div%

    0.0

  • CPS (₹)

    -0.50

  • EPS (₹)

    -2.20

  • Traded Value (₹ in Lakhs)

    9.84

  • 52 Week High

    9.99

  • 52 Week Low

    1.99

  • Price BSE

    4.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    9.84

  • P/C Ratio

    -8.20

  • P/E Ratio

    -1.80

  • Price Vs.BV

    -2.20

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar
INCOME :            
Sales Turnover 0.00 0.00 0.00 0.00 0.00 0.00
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00
Other Income 0.08 0.02 0.02 0.02 0.04 0.03
Stock Adjustments 0.00 0.00 0.00 0.00 0.00 0.00
Total Income 0.08 0.02 0.02 0.02 0.04 0.03
EXPENDITURE :            
Raw Materials 0.00 0.00 0.00 0.00 0.00 0.00
Power and Fuel Cost 0.04 0.14 0.12 0.10 0.28 0.42
Employee Cost 0.19 0.25 0.23 0.72 1.39 1.80
Other Manufacturing Expenses 0.02 0.00 0.00 0.00 0.00 0.00
Selling and Administration Expenses 0.74 0.12 0.14 0.11 0.15 0.14
Miscellaneous Expenses 0.24 0.37 1.01 9.57 0.96 -1.67
Employee Benefit Expenses 0.19 0.25 0.23 0.72 1.39 1.80
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1.23 0.87 1.50 10.50 2.79 0.69
Operating Profit -1.16 -0.86 -1.48 -10.49 -2.75 -0.66
Interest 0.00 0.00 0.00 0.13 10.84 14.47
Gross Profit -1.16 -0.86 -1.48 -10.62 -13.59 -15.13
Depreciation 4.07 4.07 4.07 4.61 5.64 5.88
Profit Before Tax -5.23 -4.93 -5.55 -15.23 -19.23 -21.01
Current Tax 0.00 0.00 0.00 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00
Reported Net Profit -5.23 -4.93 -5.55 -15.23 -19.23 -21.01
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit -5.23 -4.93 -5.55 -15.23 -19.23 -21.01
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward -202.34 -197.41 -191.86 -176.63 -157.40 -136.39
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -207.57 -202.34 -197.41 -191.86 -176.63 -157.40
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr -2.20 -2.07 -2.33 -6.39 -8.07 -8.82
Earnings Per Share(Adj)-Unit Curr -2.20 -2.07 -2.33 -6.39 -8.07 -8.82
Book Value -57.98 -55.79 -53.72 -51.39 -45.00 -36.92
Book Value(Adj)-Unit Curr -57.98 -55.79 -53.72 -51.39 -45.00 -36.92

Shareholding Pattern

  • Promoter Group

    44.95%

  • Public Share Holding

    55.05%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,709,100 44.95 10,709,100 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 10,709,100 44.95 10,709,100 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 100 0.00 0 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 100 0.00 0 1
2] Non Institution
Bodies Corporate 998,997 4.19 961,796 76
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 187,328 0.79 187,328 48
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 960,753 4.03 960,153 182
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 5,287,515 22.19 5,287,515 97
Individuals holding nominal share capital up to Rs. 1 lakh 5,605,821 23.53 5,506,016 7,328
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 75,386 0.32 75,386 1
Sub Total 13,115,800 55.05 12,978,194 7,732
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 23,825,000 100.00 23,687,294 7,734

Company Background

Kobo Biotech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Kobo Biotech Ltd
  • BSE Code : 6012.0
  • ISIN : INE881A01015

  • Incorporation Year

    1993

  • Registered Office

    Ground Flr D No 8-2-684/J/8/A
    Bhavani Nagar Banjara Hills, Hyderabad,
    Telangana-500034

  • Telephone

  • FAX

  • Chairman

    Ajit Kamath

  • Managing Director

  • Company Secretary

    Jignesh Patel

  • Auditor

    A N Shah & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    XL Softech Systems Ltd
    Plot No 3 Sagar Soci,
    Road No 2 ,Banjara Hills
    Mumbai - Hyderabad - 500034

Kobo Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Kobo Biotech 4.13 0.08 0.00 -1.88 0.00
Abbott India 27,223.20 7,217.19 6,929.05 35.83 43.78
Astrazeneca Phar 6,712.15 2,304.07 2,275.58 98.93 27.86
Glaxosmi. Pharma 2,871.50 3,932.76 3,790.20 45.87 58.17
Novartis India 1,976.65 393.10 354.33 49.92 15.94
Cipla 1,381.00 20,102.60 18,979.95 36.29 13.88
Bliss GVS Pharma 690.40 773.53 729.81 64.16 12.51
Amrutanjan Healt 500.25 520.13 502.55 26.79 24.16
Fermenta Biotec. 471.40 474.15 450.25 22.01 18.77
Guj. Themis Bio. 411.75 168.25 165.82 110.09 18.05
Ambalal Sarabhai 38.82 19.52 3.94 71.89 6.77